SCHEMBL3805658

SCHEMBL3805658

CN(c1ccccc1Cc1cc(C(F)(F)F)cc(C(F)(F)F)c1)[C@H]1C[C@@H](C(=O)N2CCN(c3cccc(C(F)(F)F)c3)CC2)N(Cc2ccccc2)C1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 6/20 0.44
MAPT P10636 4/20 0.44
SMN1; SMN2 Q16637 3/20 0.44
HTT P42858 3/20 0.44
TSHR P16473 3/20 0.44
CHRM4 P08173 1/20 0.44
ALDH1A1 P00352 4/20 0.44
POLB P06746 3/20 0.43
KMT2A Q03164 4/20 0.43
MEN1 O00255 2/20 0.42
CYP1A2 P05177 1/20 0.41
CYP3A4 P08684 1/20 0.41
CYP2D6 P10635 1/20 0.41
CYP2C9 P11712 1/20 0.41
CYP2C19 P33261 1/20 0.41
NPSR1 Q6W5P4 1/20 0.41
NR1H2 P55055 1/20 0.41
NR1H3 Q13133 1/20 0.41
HPGD P15428 1/20 0.41
KDM4E B2RXH2 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2817106 0.86 CHRM4 (0.47) LMNAMAPTSMN1; SMN2HTTTSHR
SCHEMBL3638622 0.86 CHRM4 (0.47) LMNAMAPTSMN1; SMN2HTTTSHR
SCHEMBL2817840 0.80 POLB (0.44) LMNAMAPTSMN1; SMN2HTTTSHR
SCHEMBL2822473 0.80 KMT2A (0.41) LMNAMAPTSMN1; SMN2CHRM4ALDH1A1
SCHEMBL3641058 0.80 KMT2A (0.41) LMNAMAPTSMN1; SMN2CHRM4ALDH1A1
SCHEMBL2820467 0.80 LMNA (0.49) LMNAMAPTSMN1; SMN2HTTTSHR
SCHEMBL3638063 0.79 CHRM4 (0.52) LMNAMAPTSMN1; SMN2HTTTSHR
SCHEMBL2818101 0.79 CHRM4 (0.52) LMNAMAPTSMN1; SMN2HTTTSHR
SCHEMBL2817332 0.78 CHRM4 (0.53) LMNAMAPTSMN1; SMN2HTTTSHR
SCHEMBL3979720 0.75 NPBWR1 (0.42) LMNAMAPTSMN1; SMN2HTTTSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2155672-A1 PROLINAMIDE DERIVATIVES AS NK3 ANTAGONISTS F. Hoffmann-Roche AG (CH) 2010-02-24 EP disclosed
WO-2008148689-A1 PROLINAMIDE DERIVATIVES AS NK3 ANTAGONISTS F. HOFFMANN-LA ROCHE AG (CH) 2008-12-11 WO disclosed